by Dr. Neville Wilson 30 Jan 2013   Tredaptive was introduced into the European drug market on 3rd July 2008, as a pharmaceutical formulation designed to treat certain forms of mixed  dyslipidaemia in patients judged to be at risk of cardiovascular disease. On the basis of…